Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The market has rediscovered the stock of healthcare service provider CVS Health.

CVS Health: Still Great Upside Potential

Anthem

Cigna

UnitedHealth Group

UnitedHealth Group, reported $4.9bn in profits in the first quarter of 2021 while CVS Health reported $2.2bn

US health insurers report billions in first quarter as small providers face stress

The investors were more than happy with CVS' Q1 performance as well as revised guidance, and the stock rose 4%, post the earnings announcement. Now that over 44% of the U.S. population has received at least one dose of vaccine, the company's retail sales are expected to rise, boding well for CVS.

Should You Buy CVS Health Stock After Q1 Beat?

WOONSOCKET, R.I., May 6, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Sunday, May 9 at 19 select CVS Pharmacy locations throughout New Hampshire.

CVS Health to Administer No-Cost COVID-19 Vaccines at 19 Select CVS Pharmacy Locations in New Hampshire

Merck

SSR Mining

Bargains abound for patient long-term investors.

3 Value Stocks That'll Make You Richer in May (and Beyond)

Retail pharmacy and health care provider CVS Health Inc. ( CVS , Financial) announced revenue and earnings that edged past analyst estimates on Tuesday.

CVS Health Beats Revenue Estimates on Health Care Growth

CVS Health is looking to sell individual coverage with the “CVS-Aetna” brand under the Affordable Care Act in up to eight states for 2022.

CVS-Aetna Branded Obamacare Plans Target 8 States For 2022 Launch

CVS Health Corp. said it has recently seen a decline in the number of adults coming in for COVID-19 vaccine shots, but its outlook for the rest of the year assumes gains from the administration of pediatric vaccines.

CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline

CVS Health Corporation (CVS) CEO Karen Lynch on Q1 2021 Results - Earnings Call Transcript

Before the opening bell on May 4, CVS Health Corp. ( CVS , Financial) released first-quarter 2021 results, wherein both earnings and revenue topped Wall Street's expectations due to solid retail and pharmacy service sales as more customers visited stores for Coronavirus vaccinations, tests and prescriptions.

CVS Shares Jump in Premarket Trading as Earnings Beat Estimates

CVS Health's (CVS) revenues across all the three operating segments improve in Q1. Increased guidance amid the pandemic scenario is another positive.

CVS Health (CVS) Q1 Earnings Beat Estimates, EPS View Up

CVS Health reported strong first quarter results with revenues at $69 billion, up 3.5% from the same period last year.

CVS Health Revenues Up 3.5% For First Quarter

CVS Health Corporation (NYSE: CVS) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY21 EPS guidance above estimates.

Why Are CVS Shares Trading Higher Today?

As a frontline healthcare company, it is impossible for CVS not to look back to a year ago, when the early stages of COVID lockdowns had store shelves picked bare as consumers panic-bought everything from hand sanitizer to toilet paper in an effort to prepare for the unknown. Fast-forward to 2021, and the Rhode Island-based […]

CVS Grinds Out Revenue Growth In The Face Of Year-Ago COVID Comps

All of the company's segments delivered solid growth.

How CVS Health Beat Expectations in Q1

CVS Health reported more than $2 billion in first quarter profits thanks to an influx of customers seeking Covid-19 diagnostic tests and vaccines.

CVS Profits Jump As Customers Flock To Covid-19 Vaccines, Tests

CVS Health beat Wall Street expectations and after releasing projections earlier this year that disappointed analysts, a new outlook Tuesday exceeds those levels.

CVS raises outlook on COVID-19, Medicare products

CVS Health (CVS) delivered earnings and revenue surprises of 18.60% and 0.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Q1 Earnings and Revenues Top Estimates

CVS Health Corp. (NYSE: CVS) said on Tuesday that its profit and sales came in better than expected in the fiscal first quarter as all of its business segments showed resilience in recent months. On the back of hawkish quarterly performance, the company raised its guidance for the full financial year.

3 key takeaways from CVS Health's Q1 earnings report

CVS Health Corporation (NYSE: CVS) shares moved higher in the premarket after the company reported better than expected Q1 earnings. Overall revenues increased 3.5% Y/Y to $69.1 billion, driven by growth across all segments.

CVS Health Shares Are Trading Higher On Q1 Earnings Beat, Raised FY21 EPS Guidance

CVS Health outpaced analysts' expectations for first-quarter earnings and revenue.

CVS Health earnings beats expectations for first quarter, raises forecast for year

Shares of CVS Health Corp. rallied 3.6% toward a 2 1/2-year high in premarket trading Tuesday, after the drugstore chain and health care services company reported first-quarter profit and sales that rose above expectations, with growth in all segments, and raised its full-year outlook. Net income rose to $2.22 billion, or $1.68 a share, from $2.01 billion, or $1.53 a share, in the year-ago period.

CVS stock surges to multiyear high after profit and revenue beats, raised outlook

CVS Health Corp reported a 10.5% rise in first-quarter profit on Tuesday, helped in part by higher sales at its drug stores, with more customers seeking COVID-19 tests and vaccinations.

CVS Health profit rises nearly 11% on drug store sales

Cummins

Mosaic

Pfizer

T-Mobile US

Some of the stocks that may grab investor focus today are: Wall Street expects CVS Health Corp (NYSE: CVS) to report quarterly earnings at $1.71 per share on revenue of $68.39 billion before the opening bell. CVS shares rose 2.5% to $79.66 in after-hours trading.

5 Stocks To Watch For May 4, 2021

Rite Aid

Walgreens

The drugstore chains are also expanding community clinics and signing deals with employers to reach Americans who may be busy or hesitant.

News for CVS Health Stock (CVS)